32827351|t|Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease.
32827351|a|INTRODUCTION: Cerebrovascular pathologies including cerebral amyloid angiopathy (CAA) and blood-brain barrier (BBB) dysregulation are prominent features in the majority of Alzheimer's disease (AD) cases. METHODS: We performed neuropathologic and biochemical studies on a large, neuropathologically confirmed human AD cohort (N = 469). Amounts of endothelial tight junction proteins claudin-5 (CLDN5) and occludin (OCLN), and major AD-related molecules (amyloid beta [Abeta40], Abeta42, tau, p-tau, and apolipoprotein E) in the temporal cortex were assessed by ELISA. RESULTS: Higher levels of soluble tau, insoluble p-tau, and apolipoprotein E (apoE) were independently correlated with lower levels of endothelial tight junction proteins CLDN5 and OCLN in AD brains. Although high Abeta40 levels, APOE epsilon4, and male sex were predominantly associated with exacerbated CAA severity, those factors did not influence tight junction protein levels. DISCUSSION: Refining the molecular mechanisms connecting tau, Abeta, and apoE with cerebrovascular pathologies is critical for greater understanding of AD pathogenesis and establishing effective therapeutic interventions for the disease.
32827351	0	3	Tau	Gene	4137
32827351	8	24	apolipoprotein E	Gene	348
32827351	90	117	cerebral amyloid angiopathy	Disease	MESH:D016657
32827351	121	140	Alzheimer's disease	Disease	MESH:D000544
32827351	156	183	Cerebrovascular pathologies	Disease	MESH:D002561
32827351	194	221	cerebral amyloid angiopathy	Disease	MESH:D016657
32827351	223	226	CAA	Disease	MESH:D016657
32827351	314	333	Alzheimer's disease	Disease	MESH:D000544
32827351	335	337	AD	Disease	MESH:D000544
32827351	450	455	human	Species	9606
32827351	456	458	AD	Disease	MESH:D000544
32827351	524	533	claudin-5	Gene	7122
32827351	535	540	CLDN5	Gene	7122
32827351	546	554	occludin	Gene	100506658
32827351	556	560	OCLN	Gene	100506658
32827351	573	575	AD	Disease	MESH:D000544
32827351	595	607	amyloid beta	Gene	351
32827351	619	626	Abeta42	Gene	351
32827351	628	631	tau	Gene	4137
32827351	644	660	apolipoprotein E	Gene	348
32827351	743	746	tau	Gene	4137
32827351	769	785	apolipoprotein E	Gene	348
32827351	787	791	apoE	Gene	348
32827351	880	885	CLDN5	Gene	7122
32827351	890	894	OCLN	Gene	100506658
32827351	898	900	AD	Disease	MESH:D000544
32827351	1014	1017	CAA	Disease	MESH:D016657
32827351	1148	1151	tau	Gene	4137
32827351	1153	1158	Abeta	Gene	351
32827351	1164	1168	apoE	Gene	348
32827351	1174	1201	cerebrovascular pathologies	Disease	MESH:D002561
32827351	1243	1245	AD	Disease	MESH:D000544
32827351	Association	MESH:D002561	4137
32827351	Association	MESH:D002561	351
32827351	Association	MESH:D000544	348
32827351	Association	MESH:D000544	100506658
32827351	Negative_Correlation	4137	7122
32827351	Negative_Correlation	100506658	348
32827351	Association	MESH:D002561	348
32827351	Negative_Correlation	100506658	4137
32827351	Negative_Correlation	348	7122
32827351	Association	MESH:D000544	4137
32827351	Association	MESH:D000544	351
32827351	Association	MESH:D000544	7122

